Suppr超能文献

比较 COVID-19 与流感住院危重症患者的临床特征和结局。

Comparison of Clinical Features and Outcomes in Critically Ill Patients Hospitalized with COVID-19 versus Influenza.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine.

Division of Allergy and Infectious Diseases.

出版信息

Ann Am Thorac Soc. 2021 Apr;18(4):632-640. doi: 10.1513/AnnalsATS.202007-805OC.

Abstract

No direct comparisons of clinical features, laboratory values, and outcomes between critically ill patients with coronavirus disease (COVID-19) and patients with influenza in the United States have been reported. To evaluate the risk of mortality comparing critically ill patients with COVID-19 with patients with seasonal influenza. We retrospectively identified patients admitted to the intensive care units (ICUs) at two academic medical centers with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or influenza A or B infections between January 1, 2019, and April 15, 2020. The clinical data were obtained by medical record review. All patients except one had follow-up to hospital discharge or death. We used relative risk regression adjusting for age, sex, number of comorbidities, and maximum sequential organ failure scores on Day 1 in the ICU to determine the risk of hospital mortality and organ dysfunction in patients with COVID-19 compared with patients with influenza. We identified 65 critically ill patients with COVID-19 and 74 patients with influenza. The mean (±standard deviation) age in each group was 60.4 ± 15.7 and 56.8 ± 17.6 years, respectively. Patients with COVID-19 were more likely to be male, have a higher body mass index, and have higher rates of chronic kidney disease and diabetes. Of the patients with COVID-19, 37% identified as Hispanic, whereas 10% of the patients with influenza identified as Hispanic. A similar proportion of patients had fevers (∼40%) and lymphopenia (∼80%) on hospital presentation. The rates of acute kidney injury and shock requiring vasopressors were similar between the groups. Although the need for invasive mechanical ventilation was also similar in both groups, patients with COVID-19 had slower improvements in oxygenation, longer durations of mechanical ventilation, and lower rates of extubation than patients with influenza. The hospital mortality was 40% in patients with COVID-19 and 19% in patients with influenza (adjusted relative risk, 2.13; 95% confidence interval, 1.24-3.63;  = 0.006). The need for invasive mechanical ventilation was common in patients in the ICU for COVID-19 and influenza. Compared with those with influenza, patients in the ICU with COVID-19 had worse respiratory outcomes, including longer duration of mechanical ventilation. In addition, patients with COVID-19 were at greater risk for in-hospital mortality, independent of age, sex, comorbidities, and ICU severity of illness.

摘要

在美国,尚未有关于冠状病毒病(COVID-19)危重症患者与流感患者的临床特征、实验室值和结局的直接比较报道。为了评估比较 COVID-19 危重症患者与季节性流感患者的死亡率风险。我们回顾性地确定了 2019 年 1 月 1 日至 2020 年 4 月 15 日期间在两家学术医疗中心的重症监护病房(ICU)住院且实验室确诊为严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)或甲型或乙型流感的危重症患者。临床数据通过病历回顾获得。除 1 例患者外,所有患者均随访至出院或死亡。我们使用相对风险回归,调整 ICU 第 1 天的年龄、性别、合并症数量和最大序贯器官衰竭评分,以确定 COVID-19 患者与流感患者的住院死亡率和器官功能障碍风险。我们确定了 65 例 COVID-19 危重症患者和 74 例流感患者。两组的平均(±标准差)年龄分别为 60.4±15.7 岁和 56.8±17.6 岁。COVID-19 患者更可能为男性,体重指数更高,且慢性肾脏病和糖尿病发病率更高。COVID-19 患者中 37%为西班牙裔,而流感患者中 10%为西班牙裔。两组患者在入院时均有相似比例(约 40%)的发热和(约 80%)淋巴细胞减少症。两组急性肾损伤和需要升压药的休克发生率相似。虽然两组患者的有创机械通气需求也相似,但 COVID-19 患者的氧合改善较慢,机械通气时间较长,拔管率较低。COVID-19 患者的住院死亡率为 40%,流感患者为 19%(调整后的相对风险,2.13;95%置信区间,1.24-3.63; = 0.006)。COVID-19 和流感患者 ICU 有创机械通气需求常见。与流感患者相比,COVID-19 患者 ICU 患者的呼吸结局较差,包括机械通气时间延长。此外,COVID-19 患者的住院死亡率风险更高,独立于年龄、性别、合并症和 ICU 疾病严重程度。

相似文献

引用本文的文献

本文引用的文献

9
Asthma prolongs intubation in COVID-19.哮喘会延长新冠病毒感染疾病(COVID-19)患者的插管时间。
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2388-2391. doi: 10.1016/j.jaip.2020.05.006. Epub 2020 May 14.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验